One Approach Doesn’t Fit All: A Smarter, Whole-Body Approach to Gout & Joint Wellness

Gout isn’t the same for everyone. So why should the approach to managing it be?

For more than 25 years, Alternative Health Research has been helping people understand gout, uric acid, inflammation, and joint health from a different perspective.

Our journey began in 1998 with supplements created from firsthand experience with Gout and the frustration that often comes with trying to understand why attacks keep returning. Over the years, our focus has expanded beyond a single product or a single symptom. We have continued to learn from customers, research, nutrition, formulation, and—perhaps most importantly—the many different ways people experience gout and inflammation.

Today, our philosophy is simple:

One approach doesn’t fit all. The goal is to understand what your body needs and provide support where it matters most.

Gout Is More Than a Painful Joint

A gout attack can make it feel like the problem begins and ends in one toe, ankle, knee, or other joint.

But gout is much more complicated than that.

Uric acid is produced as part of normal metabolism. Problems can develop when uric acid accumulates and, under certain conditions, forms crystals in and around joints. Those crystals can trigger an intense inflammatory response—the familiar redness, swelling, heat, and pain associated with a gout attack.

And here’s something that is easy to overlook:

You can have an underlying uric-acid problem even when you aren’t experiencing an attack.

That is why we have never believed that simply addressing pain when it occurs tells the whole story.

A more complete approach considers the bigger picture:

  • Uric acid metabolism
  • Hydration and elimination
  • Nutrition
  • Digestive and gut health
  • The body’s inflammatory response
  • Joint structure and mobility
  • Overall nutritional status
  • Individual lifestyle and dietary factors

The objective isn’t to chase one symptom after another.

It’s to support the body from multiple angles while recognizing that different people may need different types of support.

Why a One-Size-Fits-All Approach Can Fall Short

Consider two people with gout.

One may primarily be concerned about recurring gout episodes and uric acid balance.

Another may have dealt with gout for years and now be more concerned about stiff, uncomfortable joints.

Someone else may experience broader inflammation or digestive issues alongside their joint concerns.

And another person may simply be looking for nutritional and lifestyle support after realizing that their overall health has a significant influence on how they feel.

These aren’t necessarily the same situation.

So recommending the exact same strategy to everyone doesn’t always make sense.

At Alternative Health Research, we’ve built our philosophy around different needs requiring different support.

That doesn’t mean taking everything at once.

It means understanding the role that different areas of health can play—and addressing the areas that are most relevant to the individual.

Start With the Foundation

Before thinking about specialized support, it makes sense to look at the foundation.

Nutrition matters.

The body requires vitamins, minerals, adequate hydration, and a balanced diet to carry out thousands of everyday processes. That’s one reason our philosophy has evolved beyond focusing exclusively on gout.

You can’t separate joint health completely from overall health.

This is also why our approach considers nutritional support as a foundation rather than treating it as an afterthought.

For some people, that may be the most important place to start.

For others, it may simply be one piece of a larger strategy.

Don’t Forget the Gut

The digestive system is another piece of the puzzle that is often overlooked.

Your gut is involved in digestion, nutrient absorption, immune function, and elimination. Our experience has led us to view digestive health as an important component of a comprehensive wellness strategy. Our own educational material has long incorporated gut support alongside uric-acid-focused support.

This doesn’t mean that probiotics or digestive support are a “cure” for gout.

It means that gut health deserves a place in the larger conversation about whole-body wellness.

That distinction matters.

Then Address the Individual Need

Once the foundation is considered, the approach becomes more individualized.

Is uric acid your primary concern?

Then the focus may be on supporting healthy uric acid metabolism and the body’s normal elimination processes.

Is inflammation your bigger concern?

Then broader nutritional and botanical support for a healthy inflammatory response may be more relevant.

Are your joints the biggest issue?

Then supporting joint structure, cartilage, flexibility, mobility, and connective tissue becomes another consideration.

Are several of these issues happening together?

That’s where a whole-body approach becomes particularly valuable.

The point isn’t that everyone needs every type of support.

The point is that you shouldn’t have to force your individual situation into someone else’s one-size-fits-all solution.

Our Experience Has Shaped This Approach

Alternative Health Research isn’t a company that appeared yesterday because gout became a popular topic online.

We began working in this area in 1998, when GC® GoutCare was our original product and our focus was much narrower. Since then, our experience has expanded into inflammation, digestive health, nutrition, and joint support.

Over those years, we’ve heard from people with very different experiences.

Some were dealing with their first gout episode.

Some had experienced attacks for years.

Some were primarily interested in uric acid.

Others were dealing with broader joint discomfort and inflammation.

And some were simply looking for a more comprehensive approach to their health.

That experience reinforced something we believe strongly:

There isn’t one magic answer for every person.

Good health decisions require context.

Why We Believe a Thoughtful Approach Is Better Than a “Magic Bullet”

There are plenty of products and websites promising instant solutions.

We don’t believe health works that way.

Our philosophy is based on several principles:

1. Address the Bigger Picture

Rather than focusing exclusively on pain, consider the systems and lifestyle factors that influence overall wellness.

2. Target Support to the Individual

Someone primarily concerned with uric acid may have different priorities than someone primarily concerned with joint mobility or broader inflammation.

3. Build From the Foundation

Nutrition, hydration, diet, digestive health, and lifestyle shouldn’t be ignored simply because a person is looking for a supplement.

4. Don’t Overpromise

Dietary supplements are not medications, and they shouldn’t be presented as cures for disease.

Our own website makes this distinction clear: our products are dietary supplements and are not intended to diagnose, treat, cure, or prevent disease.

5. Encourage Informed Decisions

We believe people should understand why they’re taking something rather than simply being told what to take.

That’s one reason we’ve spent so much time developing educational material around gout, uric acid, inflammation, diet, and joint health—not simply selling products.

More Than a Gout Product Company

After more than two decades, we’ve learned that people don’t really come to us because they want another bottle of capsules.

They come because they want answers.

They want to understand:

  • Why does this keep happening?
  • What is uric acid actually doing?
  • Why do my joints still bother me between attacks?
  • Does what I eat matter?
  • What role does inflammation play?
  • Does gut health matter?
  • What can I do differently?
  • And perhaps most importantly: Where do I start?

Those questions are the reason Alternative Health Research has continued to develop educational resources alongside our products.

Our goal has always been bigger than a single supplement.

It’s about helping people understand the connections between gout, uric acid, inflammation, nutrition, digestion, and joint health.


A Whole-Body Approach Doesn’t Mean Doing Everything

This may be the most important part of our philosophy.

Whole-body doesn’t mean “take everything.”

It means looking at the whole person before deciding what kind of support makes sense.

For one person, the foundation may be the priority.

For another, uric acid support may be the primary concern.

For someone else, inflammation or joint mobility may deserve more attention.

And for many people, several areas may overlap.

That’s why we think of our approach as a pathway rather than a prescription.

Start with the foundation.

Strengthen the basics.

Understand your individual needs.

Then add targeted support where appropriate.


One Approach Doesn’t Fit All. Your Health Is Personal.

After starting in 1998, we’ve had more than enough time to learn one thing:

People are different.

Their diets are different.

Their lifestyles are different.

Their health histories are different.

Their gout experiences are different.

And their goals are different.

So their approach should be allowed to be different, too.

At Alternative Health Research, we’re proud of the experience we’ve built over the years, but we’re even more interested in what that experience has taught us:

There is no single “magic bullet.”

There is a better way to think about gout and joint wellness—one that looks beyond the painful joint, considers the whole body, recognizes individual needs, and encourages informed choices.

That’s the philosophy behind our Whole-Body Approach to Gout & Joint Wellness.

Different needs. Different support. One complete picture of better health.


Learn More

We’ve been researching and educating about gout, uric acid, inflammation, nutrition, and joint health since 1998.

Explore GoutCure.com

Gout: The Other Gene That Affects Urate Levels and Gout Development

The ABCG2 gene belongs to a group of genes called the ATP-binding cassette family; genes in this family provide instructions for making proteins that transport molecules across cell membranes. In the intestines, the ABCG2 protein helps release (secrete) a substance called urate into the urine. Urate is a byproduct of certain normal biochemical reactions in the body. In the bloodstream it acts as an antioxidant, protecting cells from the damaging effects of unstable molecules called free radicals. Urate levels are regulated by the kidneys and, to a lesser extent, by the intestines.

The ABCG2 protein also transports certain drugs out of cells. For example, this protein clears some chemotherapy drugs from organs and tissues. Transport of these drugs allows them to have their intended effects and be eliminated from the body.

Continue reading “Gout: The Other Gene That Affects Urate Levels and Gout Development”

Gout: Genes that Affect Urate Levels and Gout Development

The SLC2A9 gene provides instructions for making a protein called glucose transporter 9 (GLUT9). This protein is found mainly in the kidneys, specifically in structures called proximal tubules. These structures help to reabsorb needed nutrients, water, and other materials into the blood and excrete unneeded substances into the urine. Within the proximal tubules, the GLUT9 protein helps reabsorb or excrete a substance called urate. Urate is a byproduct of certain normal biochemical reactions in the body. In the bloodstream it acts as an antioxidant, protecting cells from the damaging effects of unstable molecules called free radicals. When more urate is needed in the body, the GLUT9 protein helps reabsorb it into the bloodstream. Most urate that is filtered through the kidneys is reabsorbed into the bloodstream; about 10 percent is released into urine.

The GLUT9 protein also plays a role in reabsorbing and excreting the simple sugar glucose.

Continue reading “Gout: Genes that Affect Urate Levels and Gout Development”

Gout: Genetics or Lifestyle Driven?

Genetic and genetic mutations can certainly play a role in disease, however, poor nutrition and a sedentary lifestyle can greatly increase the risk. Gout is a common condition, but it occurs more frequently in some populations than others. For example, gout occurs in 1 percent of people with Asian ancestry, 3 to 4 percent of people with European ancestry, and 6 to 8 percent of Indigenous (native) Taiwanese peoples and Māori from New Zealand.


In about 15 percent of people with gout, urate accumulates in the kidneys
and forms kidney stones . As the condition worsens, urate crystals can also be deposited under the skin or in other soft tissue, forming a nodule called a tophus (plural: tophi). These tophi often form in the hands, elbows, or feet. Tophi do not typically cause pain, but they can become inflamed, infected, or ooze fluid. Depending on their location, tophi can interfere with movements such as walking or gripping objects.

Continue reading “Gout: Genetics or Lifestyle Driven?”

Gout and Metabolic Disease: Can Probiotics help?

As we know, many studies have linked Gout with chronic inflammation and obesity.  Both conditions contribute a group of factors that increase the risks of heart disease, stroke, and diabetes – also known as metabolic syndrome.  Metabolic syndrome is a cluster of biochemical and physiological abnormalities affecting an estimated 50 million Americans.

Continue reading “Gout and Metabolic Disease: Can Probiotics help?”

What can you do to alleviate Gout symptoms?

1) Try to get an accurate diagnosis if possible.

HOWEVER, these suggestions are accurate and helpful with any inflammatory attack and can be followed, regardless of a firm diagnosis. Blood testing can be very misleading. Arthrocentesis, or joint aspiration, is the only secure method of evaluating any crystallized deposits in the joints.

2) Take the right anti-inflammatory medications. Continue reading “What can you do to alleviate Gout symptoms?”

FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)



Uloric (Febuxostat) was FDA approved in 2009 as a means to treat Gout, a form of arthritis. The FDA has since concluded that there is an increased risk of heart-related death and death from all causes from Uloric and now requiring a boxed label warning.

The makers of Uloric (Febuxostat) are also recommending that health care professionals reserve prescribing it only to patients that have failed to achieve relief from Allopurinol or those that were unable to tolerate Allopurinol.

The makers of Uloric, Takeda Pharmaceuticals, were forced to include a “precaution” about possible cardiovascular events in patients at the time of release but has since been updated to the most prominent warning, a boxed warning. Sadly, Takeda Pharmaceuticals was able to manufacture and sell Uloric in the US without any complication warning on the drug’s label for years.

A safety trial was conducted to compare the risks posed by both Allopurinol and Uloric. 15 deaths from heart-related causes per 1,000 patients taking Uloric was observed over a year’s time compared to 11 deaths from heart-related causes per 1,000 treated with Allopurinol. Additionally, 26 deaths from any cause, per 1,000 patients, was observed with Uloric use over that year compared to 22 deaths per 1,000 from Allopurinol. This trial, known as the CARE trial, suggested that Uloric was connected to significantly higher risk for fatal cardiovascular events like heart attacks, strokes, and unstable anginas.

The FDA has been fully aware of these potential complications as early as 2009 and even attempted to minimize the heart problems that Uloric could cause by only approving 40mg and 80mg doses as opposed to the 80mg and 120mg doses that Takeda Pharmaceuticals had requested. Sadly, it took until 2018 for the FDA to require the box label warning based on the results of the postmarket trial that was conducted (CARES).

Uloric (Febuxostat) has also been linked to abnormal liver function. People taking Uloric were shown to have three times higher than normal levels of transaminase. While it remains unlcear as to whether Uloric directly heightens those levels, physicians who prescribe Uloric are supposed to conduct a baseline liver test panel prior to starting Uloric and then continue to monitor for any changes.

Uloric (Febuxostat) has also been linked to severe and potentially fatal allergic reactions. Stevens-Johnson syndrome being one of these observations. Approximately one in 10 people who develop this syndrome fall victim and die from the disease.

The deceptive and faulty marketing that has allowed for years of uninformed use regarding the risk of cardiovascular events has led to numerous lawsuits against Takeda Pharmaceuticals.

Learn More Uloric (Febuxostat)

Learn More About Other Prescription Drugs for Gout

A Careful and Healing Gout Diet

Is it OK to walk with gout?

Medical News Today: It is safe for people to walk with gout. In fact, doing joint friendly activities such as walking can help improve gout-related pain.

Gout is a form of arthritis that usually affects the big toe joint, but it can also affect the lesser toes, ankles, and knees. It normally affects one joint at a time.

People with gout may find it difficult to carry out physical activity, or they may be worried that physical activity will make their gout worse.

This article will examine whether or not it is safe to walk with gout. It will also cover how to manage, treat, and prevent this condition.

Continue reading “Is it OK to walk with gout?”

Hyperuricemia as a potential plausible risk factor for periodontitis

Abstract

Author:  Zi-yun Chen,Lu-wen Ye,Li Zhao,Zhao-jia Liang,Ting Yu,Jie Gao

Publication:  Medical Hypotheses

Publisher: Elsevier

Date: April 2020

Elevated blood uric acid (UA) levels have been positively associated with the severity of periodontitis. It thus brings out a hypothesis that hyperuricemia, a pathological elevation of blood UA, might be a risk factor for periodontitis. Namely, periodontitis individuals with Hu might acquire more severe periodontal destruction compared to those without Hu. To support the hypothesis, four aspects of evidences are proposed.

Continue reading “Hyperuricemia as a potential plausible risk factor for periodontitis”

In-hospital cardiac procedures up for those with gout, rheumatoid arthritis

(HealthDay)—Rates of in-hospital cardiac procedures continued to increase in people with gout and rheumatoid arthritis (RA) from 1998 to 2014, although they decreased for the general population, according to a study published online Feb. 25 in Therapeutic Advances in Musculoskeletal Disease.Jasvinder A. Singh, M.B.B.S., M.P.H., and John Cleveland, M.D., both from the University of Alabama at Birmingham, used data from the U.S. National Inpatient Sample (1998 to 2014) to examine the frequency of seven common cardiac and orthopedic procedures in hospitalized people with gout and RA compared to the general population.

Continue reading “In-hospital cardiac procedures up for those with gout, rheumatoid arthritis”
error

Enjoy this blog? Please spread the word :)